搜尋結果
British firms still ‘pessimistic’ on China despite suite of policy changes
South China Morning Post· 7 小時前“Despite this, we recognise the remarkable progress in areas such as intellectual property ...
US tariffs on China’s cleantech exports could spark more action | FinanceAsia
Finance Asia· 12 小時前The White House has increased tariffs on a slew of Chinese imports predominantly targeting ...
AstraZeneca invests $1.5bn in Singapore facility for next-generation cancer drugs | FinanceAsia
Finance Asia· 23 小時前... pharmaceutical giant AstraZeneca has said it plans to build a $1.5 billion manufacturing ...
AstraZeneca targets $80 billion in total revenue by 2030 in 'post-Covid era'
CNBC· 24 小時前The Astrazeneca logo is pictured at the World Artificial Intelligence Conference 2021 in ...
Earnings Preview: What To Expect From Toll Brothers
Forbes· 1 日前is scheduled to report earnings after Tuesday’s close. The stock hit a record high near ...
Council Post: Navigating The Data Maze: AI's Role In Strategic Decision-Making
Forbes· 1 日前From corporate boardrooms to manufacturing floors, the exponential growth of data is impacting ...
SAP BrandVoice: AI And Powerful Partnerships Allows Arkema To Rethink Its Supply Chain
Forbes· 1 日前“Building reliable chemical supply chains is all about collaboration,” said Justin Lanyon, ...
Can Antora Energy Solve Green Energy Challenge For Industry?
Forbes· 1 日前Sustainable energy sources from wind and solar are essential to reducing carbon emissions from ...
AstraZeneca to build $1.5-bln cancer drug plant in Singapore
Reuters· 2 日前, opens new tab plans to build a $1.5 billion manufacturing facility in Singapore to produce a ...
AstraZeneca Invests US$1.5 Billion in new Singapore facility for cancer drug manufacturing
Dimsum Daily· 2 日前20th May 2024 – (Singapore) AstraZeneca has unveiled plans to establish a new $1.5 billion manufacturing